bioeng_admin
2012-10-25 19:08:42
0
112
우리학과 졸업생인 강주헌 박사(2004.02 석사, 2008.02 박사; 지도교수 박제균)가 최근 현 소속기관인 Harvard 대학교 Wyss Institute(http://wyss.harvard.edu/viewpage/about-us/about-us)의 Wyss Technology Development Fellow로 선정되었습니다. Wyss Fellow는 수백명의 연구원(Post-doc 만 60여명 포함)이 근무하는 Wyss 연구소에서 현재 9명 정도밖에 없는 매우 명예로운 자리라고 합니다.
축하드립니다.
관련링크: http://wyss.harvard.edu/viewpage/88/technology-development-fellows
Joo H. Kang received double Bachelor's degrees in Chemical Engineering and Life Science from Sogang University in 2002 and his M.S. and Ph.D. in Bioengineering from Korea Advanced Institute of Science and Technology (KAIST) in 2004 and 2008, respectively. He also received the Best Ph.D. Dissertation Award in 2008. He joined the Ingber group at Children's Hospital Boston as a research fellow in 2009, where he worked on human progenitor cells for vasculogenesis and breast tumor metastasis using biomimetic microsystems. He continued his work at the Wyss Institute as a postdoctoral research fellow under the supervision of Don Ingber from 2010, where he developed the biomimetic Spleen-on-a-chip system for sepsis therapy. His research interests include micro- and nanotechnolgies to study infectious diseases, cancer metastasis, magnetophoresis, and various fluid dynamic principles in the micro- and nano-meter regime. Contact: joo.kang@wyss.harvard.edu.
축하드립니다.
관련링크: http://wyss.harvard.edu/viewpage/88/technology-development-fellows
Joo H. Kang received double Bachelor's degrees in Chemical Engineering and Life Science from Sogang University in 2002 and his M.S. and Ph.D. in Bioengineering from Korea Advanced Institute of Science and Technology (KAIST) in 2004 and 2008, respectively. He also received the Best Ph.D. Dissertation Award in 2008. He joined the Ingber group at Children's Hospital Boston as a research fellow in 2009, where he worked on human progenitor cells for vasculogenesis and breast tumor metastasis using biomimetic microsystems. He continued his work at the Wyss Institute as a postdoctoral research fellow under the supervision of Don Ingber from 2010, where he developed the biomimetic Spleen-on-a-chip system for sepsis therapy. His research interests include micro- and nanotechnolgies to study infectious diseases, cancer metastasis, magnetophoresis, and various fluid dynamic principles in the micro- and nano-meter regime. Contact: joo.kang@wyss.harvard.edu.
